Non‐invasive metabolic biomarkers in initial cognitive impairment in patients with diabetes: A systematic review and meta‐analysis
Nicht-invasive metabolische Biomarker bei initialer kognitiver Beeinträchtigung bei Patient:innen mit Diabetes: systematische Übersicht und Metaanalyse
Diabetes, Obesity and Metabolism · 2024-12 · 26 (12) · 5519-5536
DOI: 10.1111/dom.15916 ↗Auf einen Blick
Die Übersichtsarbeit fand bei früher diabetischer kognitiver Beeinträchtigung veränderte Hirnmetaboliten. Besonders betroffen waren myo-Inositol, Glutamat, Glx und NAA/Cr im Hippocampus.
Fragestellung
Welche dysregulierten Metaboliten eignen sich als potenzielle Biomarker für frühe diabetische kognitive Beeinträchtigung?
Methode
Systematische Suche in PubMed, Embase, Web of Science und Cochrane bis März 2024; qualitative Übersicht klinischer Studien und Metaanalyse von Metabolit-Markern.
Ergebnisse
774 eindeutige Publikationen mit 4.357 Teilnehmenden; 13 klinische Studien für den Vergleich DCI vs. Kontrolle. Metaanalyse für 6 Hirnmetaboliten und 2 Verhältnisse; MI stieg, Glu, Glx und NAA/Cr fielen.
Schlussfolgerung der Autor:innen
Die Autor:innen schlussfolgern, dass MI-, Glu- und Glx-Konzentrationen sowie NAA/Cr-Raten im Hippocampus als metabolische Biomarker bei früher DCI dienen könnten.
Kernaussagen
- 13 klinische Studien berichteten Metabolit-Unterschiede zwischen DCI und Kontrolle
- MI war erhöht, Glu, Glx und NAA/Cr waren erniedrigt
- Der Hippocampus zeigte die sensitivsten metabolischen Veränderungen
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Metaanalyse in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 04.09.2024. Verfasst von Meng-Di Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Digital Quality Evaluation of Chinese Materia Medica of State Administration of TCM and Engineering and Technology Research Center …. Hauptthemen laut MEDLINE: Biomarkers, Cognitive Dysfunction, Diabetes Complications, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Key Project of Department of Education of Guangdong Province, Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
Diabetic cognitive impairment (DCI), considered one of the most severe and commonly overlooked complications of diabetes, has shown inconsistent findings regarding the metabolic profiles in DCI patients. This systematic review and meta‐analysis aimed to identify dysregulated metabolites as potential biomarkers for early DCI, providing valuable insights into the underlying pathophysiological mechanisms. Materials and Methods A systematic search of four databases, namely PubMed, Embase, Web of Science and Cochrane, was conducted up to March 2024. Subsequently, a qualitative review of clinical studies was performed followed by a meta‐analysis of metabolite markers. Finally, the sources of heterogeneity were explored through subgroup and sensitivity analyses.
Results
A total of 774 unique publications involving 4357 participants and the identification of multiple metabolites were retrieved. Of these, 13 clinical studies reported metabolite differences between the DCI and control groups. Meta‐analysis was conducted for six brain metabolites and two metabolite ratios. The results revealed a significant increase in myo‐inositol (MI) concentration and decreases in glutamate (Glu), Glx (glutamate and glutamine) and N ‐acetylaspartate/creatine (NAA/Cr) ratios in DCI, which have been identified as the most sensitive metabolic biomarkers for evaluating DCI progression. Notably, brain metabolic changes associated with cognitive impairment are more pronounced in type 2 diabetes mellitus than in type 1 diabetes mellitus, and the hippocampus emerged as the most sensitive brain region regarding metabolic changes associated with DCI.
Conclusions
Our results suggest that MI, Glu, and Glx concentrations and NAA/Cr ratios within the hippocampus may serve as metabolic biomarkers for patients with early‐stage DCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Digital Quality Evaluation of Chinese Materia Medica of State Administration of TCM and Engineering and Technology Research Center for Chinese Materia Medica Quality of Guangdong Province, Guangdong Ph…
- School of Pharmaceutical Sciences, China-Pakistan International Science and Technology Innovation Cooperation Base for Ethnic Medicine Development in Hunan Province, Hunan University of Medicine, Huaihua City, China.
ORCID-Profile: Dan Tang
Förderung
- Key Project of Department of Education of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province
- National Natural Science Foundation of China
- Hunan University of Medicine High-Level Talent Introduction Startup Funds
Zitieren
APA
Chen, M. D., Deng, C. F., Chen, P. F., Li, A., Wu, H. Z., Ouyang, F., Hu, X. G., Liu, J. X., Wang, S. M., & Tang, D. (2024). Non‐invasive metabolic biomarkers in initial cognitive impairment in patients with diabetes: A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism, 26(12), 5519-5536. https://doi.org/10.1111/dom.15916
Vancouver
Chen MD, Deng CF, Chen PF, Li A, Wu HZ, Ouyang F, et al. Non‐invasive metabolic biomarkers in initial cognitive impairment in patients with diabetes: A systematic review and meta‐analysis. Diabetes, Obesity and Metabolism. 2024;26(12):5519-5536. doi:10.1111/dom.15916
BibTeX
@article{Chen2024,
author = {Chen, Meng-Di and Deng, Chao-Fan and Chen, Peng-Fei and Li, Ao and Wu, Hua-Ze and Ouyang, Fan and Hu, Xu-Guang and Liu, Jian-Xin and Wang, Shu-Mei and Tang, Dan},
title = {Non‐invasive metabolic biomarkers in initial cognitive impairment in patients with diabetes: A systematic review and meta‐analysis},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
volume = {26},
number = {12},
pages = {5519--5536},
doi = {10.1111/dom.15916}
}
EUVIMED